NVAX
Novavax Inc
Price:  
4.94 
USD
Volume:  
18,635,908.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Novavax EV/EBITDA

-1072.1%
Upside

As of 2024-03-01, the EV/EBITDA ratio of Novavax Inc (NVAX) is -0.77. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Novavax's latest enterprise value is 372.06 mil USD. Novavax's TTM EBITDA according to its financial statements is -484.00 mil USD. Dividing these 2 quantities gives us the above Novavax EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 12.8x - 20.9x 14.8x
Forward P/E multiples 15.9x - 24.6x 19.2x
Fair Price (44.87) - (59.85) (48.02)
Upside -1008.3% - -1311.6% -1072.1%
4.94 USD
Stock Price
(48.02) USD
Fair Price

Novavax EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-29 -0.77
2024-02-28 -0.59
2024-02-27 -1.13
2024-02-26 -0.96
2024-02-23 -0.89
2024-02-22 -0.75
2024-02-21 -0.45
2024-02-20 -0.50
2024-02-16 -0.51
2024-02-15 -0.55
2024-02-14 -0.49
2024-02-13 -0.42
2024-02-12 -0.50
2024-02-09 -0.46
2024-02-08 -0.38
2024-02-07 -0.38
2024-02-06 -0.43
2024-02-05 -0.37
2024-02-02 -0.43
2024-02-01 -0.46
2024-01-31 -0.45
2024-01-30 -0.46
2024-01-29 -0.52
2024-01-26 -0.47
2024-01-25 -0.49
2024-01-24 -0.47
2024-01-23 -0.54
2024-01-22 -0.51
2024-01-19 -0.47
2024-01-18 -0.49
2024-01-17 -0.52
2024-01-16 -0.57
2024-01-12 -0.65
2024-01-11 -0.64
2024-01-10 -0.74
2024-01-09 -0.73
2024-01-08 -0.84
2024-01-05 -0.79
2024-01-04 -0.84
2024-01-03 -0.75
2024-01-02 -0.80
2023-12-29 -0.72
2023-12-28 -0.76
2023-12-27 -0.77
2023-12-26 -0.81
2023-12-22 -0.81
2023-12-21 -0.77
2023-12-20 -0.76
2023-12-19 -0.87
2023-12-18 -0.84